Contribution of recurrent venous thrombosis and inherited thrombophilia to the pathogenesis of postthrombotic syndrome

Clinical and Applied Thrombosis/Hemostasis

Volumn 21, Issue 1, 2015, Pages 87-90

  Kreidy, Raghid ^a  

^a UNIVERSITY OF BALAMAND   (Lebanon)

Author keywords

deep vein thrombosis; post thrombotic syndrome; recurrence; thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ANTITHROMBIN III DEFICIENCY; ARTICLE; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; HUMAN; HYPERHOMOCYSTEINEMIA; MEDICAL RECORD REVIEW; POSTTHROMBOSIS SYNDROME; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT DISEASE; RETROSPECTIVE STUDY; THROMBOPHILIA; VEIN THROMBOSIS; ADULT; AGED; COMPLICATION; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; POSTTHROMBOTIC SYNDROME; RISK FACTOR; VASCULAR SURGERY; VENOUS THROMBOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTTHROMBOTIC SYNDROME; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHILIA; VASCULAR SURGICAL PROCEDURES; VENOUS THROMBOSIS;

EID: 84914146078     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613497423     Document Type: Article

References (34)

1. Delluc A, Gouedard C, De Saint Martin L, et al. Incidence, risk factors and skin manifestations of post-thrombotic syndrome: a four-year follow-up of patients included in the EDITH study. Rev Med Interne. 2010 ; 31 (11). 729-734
2. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996 ; 125 (1). 1-7
3. Rosendaal FR. Venous thrombosis: a multi-causal disease. Lancet. 1999 ; 353 (9159). 1167-1173
4. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology. 1997 ; 48 (1). 67-69
5. Porter JM, Moneta GL. Reporting standards in venous disease: an update. International consensus committee on chronic venous disease. J Vasc Surg. 1995 ; 21 (4). 635-645
6. Eklöf B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004 ; 40 (6). 1248-1252
7. Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. 2010 ; 2010: 216-220
8. Reich-Schupke S, Altmeyer P, Stucker M. What do we know of post-thrombotic syndrome? current status of post-thrombotic syndrome in adults. J Dtsch Dermatol Ges. 2010 ; 8 (2). 81-87
9. Kahn SR. The post-thrombotic syndrome. Thromb Res. 2011 ; 127 (suppl 3). S89 - S92
10. Young L, Ockelford P, Milne D, Rolphe Vyson V, Mckelvie S, Harper P. Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. J Thromb Haemost. 2006 ; 4 (9). 1919-1924
11. Prandoni P, Lensing AW, Prins MR, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002 ; 137 (12). 955-960
12. Lindmarker P, Sculman S.. The risk of ipsilateral versus controlateral recurrent deep vein thrombosis in the leg. The DURAC trial study group. J Intern Med. 2000 ; 247 (5). 601-606
13. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003 ; 362 (9383). 523-526
14. Betancourt MT, Rodger MA. Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism's patients. Acta Chir Belg. 2007 ; 107 (6). 636-640
15. Labropoulos N, Jen J, Jen H, Gasparis AP, Tassiopoulos AK. Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg. 2010 ; 251 (4). 749-753
16. Cushman M. Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program. 2005 ;: 452-457
17. Meissner MH, Caps MT, Zierler BK, et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg. 1998 ; 28 (5). 826-833
18. Watzke HH. Oral anticoagulation after a first episode of venous thromboembolism: how long? how strong?. Thromb Haemost. 1999 ; 82 (suppl 1). 124-126
19. Palareti G, Cosmi B. Legnani C, et al. D dimer testing to determine the duration of anticoagulation therapy. N Eng J Med. 2006 ; 355 (17). 1780-1789
20. Marchiori A, Mosena L, Prins MH, Prandoni P.. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G 20210 mutation. A systemic review of prospective studies. Haematologica. 2007 ; 92 (8). 1107-1114
21. Kearon C. Natural history of venous thromboembolism. Circulation. 2003 ; 107 (23 suppl 1). l22 - l30
22. Lopez-Azkarreta I, Reus S, Marco P, et al. Prospective study of the risk factors for the development of post-thrombotic syndrome after proximal deep venous thrombosis. Med Clin (Barc). 2005 ; 125 (1). 1-4
23. Meissner MH, Caps MT, Bergelin RO, Manzo RA, Strandness DE. Propagation, re-thrombosis and new thrombus formation after acute deep venous thrombosis. J Vasc Surg. 1995 ; 22 (5). 558-567
24. Beyth RJ, Cohen AM, Landefeld CS. Long-term outcomes of deep - vein thrombosis. Arch Intern Med. 1995 ; 155 (10). 1031-1037
25. Ribeaudeau F, Senet P, Cayuela JM, et al. A prospective coagulation study including resistance to activated protein C and mutations in factors V and II in venous leg ulcers. Br J Dermatol. 1999 ; 141 (2). 259-263
26. MacKenzie RK, Ludlam CA, Ruckley CV, Allan PL, Burns P, Bradbury AW. The prevalence of thrombophilia in patients with chronic venous leg ulceration. J Vasc Surg. 2002 ; 35 (4). 718-722
27. Spiezia L, Campello E, Giolo E, Villalta S, Prandoni P. Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation. J Thromb Haemost. 2010 ; 8 (1). 211-213
28. Gaber Y, Siemens HJ, Schmeller W. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers. Br J Dermatol. 2001 ; 144 (3). 546-548
29. Zutt M, Kruger U, Rosemberger A, et al. Thrombophilia in patients with chronic venous leg ulcers - a study on patients with or without post-thrombotic syndrome. J Eur Acad Dermatol Venereol. 2011 ; 25 (12). 1432-1439
30. Wiszniewski A, Bykowska K, Bilski R, Jaskowiak W, Proniewski J. Prevalence rate for inherited thrombophilia in patients with chronic and recurrent venous leg ulceration. Wound Rep Regen. 2011 ; 19 (5). 552-558
31. Maessen-Visch MB, Hamulyak K, Tazelaar DJ, Crombag N, Martino Neumann HM. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol. 1999 ; 135 (1). 41-44
32. Spiezia L, Tormene D, Pesavento R, Salmaso L, Simioni P, Prandoni P. Thrombophilia as a predictor of persistent residual venous thrombosis. Haematologica. 2008 ; 93 (3). 479-480
33. Gonzalez-Fajardo JA, Martin-Pedrosa M, Castrodeza J, Tamames S, Vaquero-Puerta C. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: comparative study of enoxaparin versus coumarin. J Vasc Surg. 2008 ; 48 (4). 953-959
34. Ramaker J, Goerdt S, Zouboulis CC, Schramm W, Orfanos CE. Recurrent thrombophlebitis and ulcera crurum as manifestations of hereditary blood coagulation disorders and Klinefelter syndrome. Discussion based on 4 case examples. Hautarzt. 1997 ; 48 (9). 634-639